Affiliation:
1. Department of Pathology, University of Iowa College of Medicine, Iowa City 52242, USA.
Abstract
Compound LB20304 is a fluoronaphthyridone carboxylic acid with a novel pyrrolidine substituent. This drug was compared with ciprofloxacin, levofloxacin, ofloxacin, and trovafloxacin against over 800 pathogens, most from blood stream infections, by National Committee for Clinical Laboratory Standards reference methods. LB20304 was the most active agent against gram-positive species including strains observed to be resistant to other fluoroquinolones and glycopeptides. The potency of LB20304 (MIC50, 0.03 micrograms/ml) against the Enterobacteriaceae was exceeded only by that of ciprofloxacin (0.015 micrograms/ml). It has limited activity against gram-negative anaerobes.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference12 articles.
1. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial;Gootz T. D.;Diagn. Microbiol. Infect. Dis.,1994
2. The in vitro activity of a new highly active quinolone DU 6859a;Jolley A.;J. Antimicrob. Chemother.,1993
3. Prevalence of important pathogens and antimicrobial activity of parenteral drugs at numerous medical centers in the United States. I. Study on the threat of emerging resistances: real or perceived;Jones R. N.;Diagn. Microbiol. Infect. Dis.,1994
4. Safety evaluation of LB20304, a new quinolone antibiotic;Kim S. I.;J. Appl. Pharmacol.,1995
5. Kim Y. K. H. Choi S. H. Kim J.-H. Chang D.-H. Nam Y.-Z. Kim J.-H. Kwak and C. Y. Hong. 1995. Synthesis and antibacterial activities of LB20304: a new fluoronaphthyridone antibiotic containing novel oxime functionalized pyrrolidine abstr. F204 p. 148. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology Washington D.C.
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献